SAMRAT PHARMA Fact Sheet, SAMRAT PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SAMRAT PHARMA Fact Sheet    (SMPH)


Revealing on July 30th: Asset Class Outlook and Economic View Post Covid 19


Here is the latest financial fact sheet of SAMRAT PHARMA. For more details, see the SAMRAT PHARMA quarterly results and SAMRAT PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

SAMRAT PHARMA Price History

Price Rs 269.7
Mkt Cap Rs m 833
Vol '000 8.3
P/E X 15.6
P/CF X 17.9
EPS (TTM) Rs 17.3
% ch % -2.9
No. of shares m 3.09
% ch week % 2.7
% ch 1-mth % 13.5
% ch 12-mth % 196.7
52 week H/L Rs 305.0/83.3
(As on Jul 28, 2021 01:37:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SAMRAT PHARMA Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
SAMRAT PHARMA EQUITY SHARE DATA
High Rs4682170164132 
Low Rs2325494947 
Sales per share (Unadj.) Rs188.0216.5260.6313.6381.2 
Earnings per share (Unadj.) Rs1.05.710.45.013.7 
Diluted earnings per shareRs1.05.710.45.013.7 
Cash flow per share (Unadj.) Rs2.47.111.76.315.1 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Dividend yield (eoy) %00000 
Book value per share (Unadj.) Rs44.549.660.064.978.7 
Adj. book value per shareRs44.549.660.064.978.7 
Shares outstanding (eoy) m3.093.093.093.093.09 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x0.20.20.40.30.2 
Avg P/E ratio x35.09.410.521.46.5 
P/CF ratio (eoy) x14.27.59.316.85.9 
Price / Book Value ratio x0.81.11.81.61.1 
Dividend payout %00000 
Avg Mkt Cap Rs m106165339328277 
No. of employees `000NANANANANA 
Total wages/salary Rs m789910 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
SAMRAT PHARMA INCOME DATA
Net Sales Rs m5816698059691,178 
Other income Rs m22256 
Total revenues Rs m5836718089741,184 
Gross profit Rs m1237603266 
Depreciation Rs m44444 
Interest Rs m5691110 
Profit before tax Rs m428492258 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m11017615 
Profit after tax Rs m318321542 
Gross profit margin %2.15.57.43.35.6 
Effective tax rate %32.836.834.628.826.8 
Net profit margin %0.52.64.01.63.6 
SAMRAT PHARMA BALANCE SHEET DATA
Current assets Rs m284283333328497 
Current liabilities Rs m205191210193339 
Net working cap to sales %13.613.715.213.913.4 
Current ratio x1.41.51.61.71.5 
Inventory Days Days163321 
Debtors Days Days10165997986 
Net fixed assets Rs m7878767587 
Share capital Rs m3131313131 
"Free" reserves Rs m107122154170212 
Net worth Rs m138153185201243 
Long term debt Rs m1512830 
Total assets Rs m362361408402583 
Interest coverage x1.95.46.73.06.9 
Debt to equity ratio x0.10.1000 
Sales to assets ratio x1.61.92.02.42.0 
Return on assets %2.26.610.06.48.9 
Return on equity %2.211.517.47.717.4 
Return on capital %6.320.730.015.827.8 
Exports to sales %20.315.512.219.05.9 
Imports to sales %72.587.980.987.194.7 
Exports (fob) Rs m1181039818469 
Imports (cif) Rs m4215886518441,115 
Fx inflow Rs m1181039818469 
Fx outflow Rs m4225886518441,116 
Net fx Rs m-304-485-553-660-1,046 
SAMRAT PHARMA CASH FLOW
From Operations Rs m -4 -32 1 24 -13 
From Investments Rs m -24 12 -24 22 -19 
From Financial Activity Rs m 23 7 15 -39 20 
Net Cashflow Rs m -4 -13 -8 6 -12 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Indian Promoters 49.3%
Foreign collaborators 0.0%
Indian inst/Mut Fund 3.2%
FIIs 3.2%
ADR/GDR 0.0%
Free float 50.7%
Shareholders 5,189
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Plot No A2 / 3445, G I D C Phase 4, Opp. P C I, Ankleshwar - 393002
E-MAIL contact@samratpharmachem.in WEB www.samratpharmachem.com
TEL 02646- 220774 FAX 02646- 251291
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
YEAR OF INC: 1992 BSE CODE: 530125 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   SMS LIFESCIENCES INDIA  PIRAMAL ENTERPRISES  KOVAI MEDICAL  TRANS ASIA CORP  PFIZER  

Compare SAMRAT PHARMA With:   SMS LIFESCIENCES INDIA  PIRAMAL ENTERPRISES  KOVAI MEDICAL  TRANS ASIA CORP  PFIZER  




Today's Market

Sensex Trades Over 300 Points Lower, Dow Futures Down by 67 Points(12:30 pm)

Share markets in India are presently trading on a negative note. The BSE Sensex is trading down by 381 points, down 0.7%, at 52,179 levels.

Views on news

Glenmark Life Sciences IPO Opens Tomorrow: Few Points to Know Before Applying (Views On News)

Jul 26, 2021

All you need to know about the IPO of Glenmark Life Sciences.

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

Bajaj Healthcare Rallies 11% on DRDO Nod to Manufacture Oral Covid Drug (Views On News)

Jul 8, 2021

Bajaj Healthcare has more than doubled investors' wealth in the year 2021 so far. The counter has delivered over 240% return in the last one year.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

KIMS Shares Make Strong Debut Listing at a 22% Premium (Views On News)

Jun 28, 2021

KIMS shares pare gains after making a strong debut on the exchanges.

More Views on News

Most Popular

RBI Opens a New Market for Investors (Fast Profits Daily)

Jul 16, 2021

You now have a new way to create wealth. Grab it with both hands.

These Are the Best Stocks to Own (Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

India's Vulture Moment Against China (Fast Profits Daily)

Jul 15, 2021

India has a great opportunity to grab market share from China. Profit from it.

Top 5 Stocks Mutual Funds Bought and Sold in June 2021 (Views On News)

Jul 15, 2021

A look at what India's top equity mutual funds bought and sold in June 2021.

Zomato: Worth a Bite? (Profit Hunter)

Jul 15, 2021

Zomato has been a consumer's delight. Can it be an investor's delight too?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SAMRAT PHARMA

  • Track your investment in SAMRAT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SAMRAT PHARMA

SAMRAT PHARMA - ADCOCK INGRAM COMPARISON

COMPARE SAMRAT PHARMA WITH

MARKET STATS